Replies to post #398641 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

The Form 4 and 10-K are both correct.

10-K - Nasrat Hakim - 295,824,820 shares - 29.1%

- "Includes 167,114,882 shares of Common Stock held and 49,701,277 shares of Common Stock due and owing to Mr. Hakim as of March 31, 2023 (the latest practicable date) for compensation earned pursuant to Mr. Hakim’s employment agreement with the Company and 79,008,661 shares of Common Stock issuable upon cash exercise of the Series J Warrants with an exercise price of $0.1521 per share."

You are correct. As of last 10K he listed 295M at 29.1%, which differs from recent Form 4.